Trade TransMedics Group Inc - TMDX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.12 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 60.47 |
| Open | 60.2 |
| 1-Year Change | -22.83% |
| Day's Range | 60.08 - 62.29 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 20, 2024 | 61.72 | 1.77 | 2.95% | 59.95 | 62.38 | 59.65 |
| Dec 19, 2024 | 60.47 | -0.51 | -0.84% | 60.98 | 62.11 | 60.08 |
| Dec 18, 2024 | 60.81 | -4.93 | -7.50% | 65.74 | 65.95 | 60.32 |
| Dec 17, 2024 | 65.61 | 5.04 | 8.32% | 60.57 | 66.36 | 60.57 |
| Dec 16, 2024 | 64.09 | 0.02 | 0.03% | 64.07 | 66.05 | 63.55 |
| Dec 13, 2024 | 64.26 | -1.03 | -1.58% | 65.29 | 66.08 | 63.38 |
| Dec 12, 2024 | 65.65 | -1.60 | -2.38% | 67.25 | 67.25 | 65.21 |
| Dec 11, 2024 | 67.34 | -1.41 | -2.05% | 68.75 | 71.00 | 66.95 |
| Dec 10, 2024 | 68.95 | -2.00 | -2.82% | 70.95 | 72.40 | 65.65 |
| Dec 9, 2024 | 69.76 | 1.35 | 1.97% | 68.41 | 71.95 | 67.52 |
| Dec 6, 2024 | 68.21 | 1.60 | 2.40% | 66.61 | 69.45 | 66.50 |
| Dec 5, 2024 | 66.20 | -5.60 | -7.80% | 71.80 | 72.37 | 66.05 |
| Dec 4, 2024 | 72.15 | 0.03 | 0.04% | 72.12 | 73.82 | 70.58 |
| Dec 3, 2024 | 71.36 | -5.99 | -7.74% | 77.35 | 78.45 | 71.20 |
| Dec 2, 2024 | 85.02 | -1.94 | -2.23% | 86.96 | 86.96 | 83.95 |
| Nov 29, 2024 | 86.47 | -0.70 | -0.80% | 87.17 | 89.11 | 86.46 |
| Nov 27, 2024 | 87.08 | 5.73 | 7.04% | 81.35 | 87.48 | 81.35 |
| Nov 26, 2024 | 80.45 | 2.49 | 3.19% | 77.96 | 81.02 | 77.96 |
| Nov 25, 2024 | 78.49 | 0.94 | 1.21% | 77.55 | 78.81 | 76.14 |
| Nov 22, 2024 | 76.04 | 0.59 | 0.78% | 75.45 | 76.79 | 72.59 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
TransMedics Group, Inc. Company profile
About TransMedics Group Inc
TransMedics Group, Inc. is a commercial-stage medical technology company. It is focused on developing organ transplant therapy for end-stage organ failure patients across multiple disease states. The Company has designed and developed organ care system (OCS) a portable organ perfusion, optimization and monitoring system that utilizes customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It has developed three OCS products, one for each of lung, heart and liver transplantations. Its OCS clinical programs include OCS Heart EXPAND Trial, OCS Heart EXPAND Continued Access Protocol, or CAP, Trial and OCS Heart PROCEED II Trials. Its organ care system (OCS) technology platform to perfuse donor organs with warm, oxygenated, nutrient-enriched blood, while maintaining the organs in a living, functioning state; the lung is breathing, the heart is beating and the liver is producing bile.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, TransMedics Group Inc revenues increased 18% to $30.3M. Net loss increased 54% to $44.2M. Revenues reflect OCS Lung net revenue segment increase of 72% to $10.7M, OCS Heart net revenue segment increase of 25% to $17.7M, United States segment increase of 14% to $21.9M, All other countries segment increase of 31% to $8.4M.
| Industry: | Advanced Medical Equipment & Technology (NEC) |
200 Minuteman Road
ANDOVER
MASSACHUSETTS 01810
US
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com